OCM2

gene
On this page

Summary

OCM2 (oncomodulin 2, HGNC:34396) is a protein-coding gene on chromosome 7q21.3, encoding Oncomodulin-2 (P0CE71).

This gene is similar to the oncomodulin gene, a high-affinity calcium ion-binding protein that belongs to the superfamily of calmodulin proteins, also known as the EF-hand proteins.

Source: NCBI Gene 4951 — RefSeq curated summary.

At a glance

  • GWAS associations: 2
  • Clinical variants (ClinVar): 21 total
  • MANE Select transcript: NM_006188

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:34396
Approved symbolOCM2
Nameoncomodulin 2
Location7q21.3
Locus typegene with protein product
StatusApproved
Ensembl geneENSG00000135175
Ensembl biotypeprotein_coding
OMIM620522
Entrez4951

Gene structure

Transcript identifiers

Ensembl transcripts: 2 — 1 protein_coding, 1 protein_coding_CDS_not_defined

ENST00000257627, ENST00000473987

RefSeq mRNA: 1 — MANE Select: NM_006188 NM_006188

CCDS: CCDS5653

Canonical transcript exons

ENST00000257627 — 4 exons

ExonStartEnd
ENSE000017888189799004497990196
ENSE000035539319798704797987156
ENSE000036283239798841697988548
ENSE000039782899798468797984983

Expression profiles

Bgee: expression breadth broad, 33 present calls, max score 90.92.

Top tissues by expression

101 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
male germ line stem cell (sensu Vertebrata) in testisCL:0000089 ∩ UBERON:000047390.92gold quality
primordial germ cell in gonadCL:0000670 ∩ UBERON:000099174.35gold quality
colonic epitheliumUBERON:000039741.93gold quality
ventricular zoneUBERON:000305336.48gold quality
cortical plateUBERON:000534336.47gold quality
bone marrow cellCL:000209236.16gold quality
bone marrowUBERON:000237135.64silver quality
ganglionic eminenceUBERON:000402335.49gold quality
prefrontal cortexUBERON:000045133.72gold quality
skeletal muscle tissueUBERON:000113433.38gold quality
tonsilUBERON:000237232.72gold quality
placentaUBERON:000198732.33gold quality
hindlimb stylopod muscleUBERON:000425232.15gold quality
primary visual cortexUBERON:000243631.49gold quality
muscle tissueUBERON:000238531.06gold quality
sural nerveUBERON:001548830.93gold quality
lymph nodeUBERON:000002930.83silver quality
stromal cell of endometriumCL:000225529.87gold quality
bloodUBERON:000017829.76gold quality
frontal cortexUBERON:000187029.56gold quality
monocyteCL:000057629.11silver quality
leukocyteCL:000073828.97silver quality
duodenumUBERON:000211428.14gold quality
anterior cingulate cortexUBERON:000983527.99gold quality
skin of abdomenUBERON:000141627.88gold quality
Brodmann (1909) area 9UBERON:001354027.79silver quality
zone of skinUBERON:000001427.74gold quality
superior frontal gyrusUBERON:000266127.59gold quality
cerebral cortexUBERON:000095627.52gold quality
skin of legUBERON:000151127.21gold quality

Single-cell (SCXA)

Detected in 1 experiment(s), a significant marker in 0.

ExperimentMarker?Max mean expression
E-ANND-3no2.10

Regulation

Is transcription factor: no

Upstream regulators (CollecTRI, top): EGR1, HIF1A

miRNA regulators (miRDB)

26 targeting OCM2, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-6873-3P100.0071.422626
HSA-MIR-6833-3P100.0070.633197
HSA-MIR-7-1-3P99.9171.534384
HSA-MIR-7-2-3P99.9171.404394
HSA-MIR-627-3P99.9071.423316
HSA-MIR-6764-5P99.7567.892304
HSA-MIR-3158-5P99.6567.511763
HSA-MIR-29899.6367.561916
HSA-MIR-1915-3P99.5866.791988
HSA-MIR-127599.4767.902749
HSA-MIR-328-5P99.0864.651000
HSA-MIR-6885-5P98.7164.33902
HSA-MIR-431798.4967.09987
HSA-MIR-126298.1766.52757
HSA-MIR-4701-3P98.1766.25788
HSA-MIR-6736-5P98.1766.43760
HSA-MIR-6757-5P98.0865.50724
HSA-MIR-4665-5P97.9167.691536
HSA-MIR-3127-5P97.5265.24786
HSA-MIR-6514-3P97.5266.50808
HSA-MIR-509-3-5P97.2167.741517
HSA-MIR-509-5P97.2167.901512
HSA-MIR-441897.0467.161372
HSA-MIR-1212896.6766.981471
HSA-MIR-6866-5P96.6468.06624
HSA-MIR-6790-3P88.1562.55113

Literature-anchored findings (GeneRIF, showing 1)

  • This study deministrated that Parvalbumin-immunoreactive neurons in the human claustrum. (PMID:23832597)

Cross-species orthologs

3 orthologs

OrganismSymbolGene ID
danio_reriopvalb5ENSDARG00000032836
mus_musculusOcmENSMUSG00000029618
rattus_norvegicusOcmENSRNOG00000001031

Paralogs (2): PVALB (ENSG00000100362), OCM (ENSG00000122543)

Protein

Protein identifiers

Oncomodulin-2P0CE71 (reviewed: P0CE71)

All UniProt accessions (1): P0CE71

UniProt curated annotations — full annotation on UniProt →

Similarity. Belongs to the parvalbumin family.

RefSeq proteins (1): NP_006179* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR002048EF_hand_domDomain
IPR008080ParvalbuminFamily
IPR011992EF-hand-dom_pairHomologous_superfamily
IPR018247EF_Hand_1_Ca_BSBinding_site

Pfam: PF13499

UniProt features (13 total): binding site 10, domain 2, chain 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-P0CE71-F191.630.82

Functional residue map

Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.

Ligand- & substrate-binding residues (10): 95; 97; 102; 52; 54; 56; 58; 63; 91; 93

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 42 (showing top): MIR298, MIR3158_5P, MIR509_5P, MIR509_3_5P, MIR12128, MIR4418, MIR4701_3P, MIR1262, MIR6736_5P, MIR6866_5P, GSE1448_ANTI_VALPHA2_VS_VBETA5_DP_THYMOCYTE_UP, GSE22886_NAIVE_CD8_TCELL_VS_NKCELL_UP, GSE24634_TREG_VS_TCONV_POST_DAY5_IL4_CONVERSION_DN, GSE25087_FETAL_VS_ADULT_TREG_DN, GSE26928_NAIVE_VS_EFF_MEMORY_CD4_TCELL_UP

GO Biological Process (0):

GO Molecular Function (2): calcium ion binding (GO:0005509), metal ion binding (GO:0046872)

GO Cellular Component (1): cytoplasm (GO:0005737)

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
metal ion binding1
cation binding1
intracellular anatomical structure1
cellular anatomical structure1

Protein interactions and networks

STRING

1365 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
OCM2SLC26A5P58743903
OCM2PITPNM1O00562864
OCM2GFI1Q99684758
OCM2STRCQ7RTU9535
OCM2ADCY6O43306512
OCM2OTOFQ9HC10496
OCM2POU4F3Q15319455
OCM2TMC1Q8TDI8437
OCM2MINAR2P59773435
OCM2PAIP2BQ9ULR5426
OCM2ATP1B3P54709425
OCM2ATOH1Q92858410
OCM2SLC1A1P43005363
OCM2TMC2Q8TDI7360
OCM2KCNA10Q16322359

IntAct

8 interactions, top by confidence:

ABTypeScore
MED12MED14psi-mi:“MI:0914”(association)0.640
OCM2ZMYM6psi-mi:“MI:0915”(physical association)0.400
OCM2TERF1psi-mi:“MI:0915”(physical association)0.370
OCM2TERF2psi-mi:“MI:0915”(physical association)0.370
OCM2TERF2IPpsi-mi:“MI:0915”(physical association)0.370
ARFGAP2OCM2psi-mi:“MI:0914”(association)0.350
ZNF708OCM2psi-mi:“MI:0914”(association)0.350

BioGRID (7): ZMYM6 (Affinity Capture-MS), OCM2 (Affinity Capture-MS), OCM2 (Affinity Capture-MS), OCM2 (Affinity Capture-MS), OCM2 (Two-hybrid), OCM2 (Two-hybrid), OCM2 (Two-hybrid)

ESM2 similar proteins: A0A1B0GWK0, O01305, O35508, P02613, P02615, P02616, P02624, P02626, P02627, P02629, P02630, P02631, P02637, P04109, P04110, P04111, P04573, P05941, P09485, P0CE71, P0CE72, P13833, P15844, P18087, P19753, P21788, P25027, P30187, P30563, P34368, P41045, P43305, P51434, P51879, P80026, P80050, P80079, P80080, P82978, Q03975

Diamond homologs: A0A1B0GWK0, A0A3F2YLV2, A0A7M4EAX1, D3GME4, O35508, O49717, P02614, P02615, P02616, P02617, P02618, P02619, P02620, P02621, P02622, P02623, P02624, P02625, P02626, P02627, P02628, P02629, P02630, P02631, P05939, P05940, P05941, P09227, P0CE71, P0CE72, P18087, P19753, P20472, P30563, P32848, P43305, P51434, P51879, P56503, P59747

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

21 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance19
Likely benign0
Benign0

Top pathogenic / likely-pathogenic (0)

SpliceAI

575 predictions. Top by Δscore:

VariantEffectΔscore
7:97987045:AC:Adonor_gain1.0000
7:97987046:CC:Cdonor_gain1.0000
7:97987046:CCCT:Cdonor_gain1.0000
7:97988414:A:ACdonor_gain1.0000
7:97988415:C:CTdonor_gain1.0000
7:97988418:A:ACdonor_gain1.0000
7:97988418:AAG:Adonor_gain1.0000
7:97988418:AAGCT:Adonor_gain1.0000
7:97987032:CA:Cdonor_gain0.9900
7:97987040:GACAT:Gdonor_loss0.9900
7:97987042:CAT:Cdonor_loss0.9900
7:97987044:T:TAdonor_loss0.9900
7:97987045:A:ACdonor_gain0.9900
7:97987045:ACCCT:Adonor_loss0.9900
7:97987046:C:CCdonor_gain0.9900
7:97988415:CTT:Cdonor_gain0.9900
7:97988415:CTTA:Cdonor_gain0.9900
7:97988419:A:Cdonor_gain0.9900
7:97988545:GGGTC:Gacceptor_gain0.9900
7:97988546:GGTCT:Gacceptor_gain0.9900
7:97988547:GTCT:Gacceptor_gain0.9900
7:97988549:C:CCacceptor_gain0.9900
7:97990052:T:Adonor_gain0.9900
7:97987152:AAAAC:Aacceptor_gain0.9800
7:97987157:C:CAacceptor_loss0.9800
7:97987158:T:Cacceptor_loss0.9800
7:97988410:G:Cdonor_gain0.9800
7:97988415:CT:Cdonor_gain0.9800
7:97988415:CTTAA:Cdonor_gain0.9800
7:97988548:TCT:Tacceptor_gain0.9800

AlphaMissense

736 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
7:97988466:G:CF48L0.995
7:97988466:G:TF48L0.995
7:97988468:A:GF48L0.995
7:97984980:A:GF103S0.993
7:97987080:C:GD91H0.991
7:97988419:A:GL64P0.991
7:97984979:G:CF103L0.990
7:97984979:G:TF103L0.990
7:97984981:A:GF103L0.990
7:97988456:C:GD52H0.990
7:97988467:A:GF48S0.990
7:97988455:T:AD52V0.989
7:97988521:A:GF30S0.989
7:97988520:G:CF30L0.988
7:97988520:G:TF30L0.988
7:97988522:A:GF30L0.988
7:97987079:T:AD91V0.987
7:97987079:T:GD91A0.987
7:97988455:T:GD52A0.987
7:97984980:A:CF103C0.986
7:97987094:A:GL86S0.985
7:97988419:A:TL64H0.985
7:97987138:A:CF71L0.984
7:97987138:A:TF71L0.984
7:97987140:A:GF71L0.984
7:97988434:A:GL59P0.984
7:97988442:G:CS56R0.984
7:97988442:G:TS56R0.984
7:97988444:T:GS56R0.984
7:97987058:A:TI98N0.983

dbSNP variants (sampled 300 via entrez): RS1000349617 (7:97984943 C>T), RS1001241628 (7:97989399 T>G), RS1003530452 (7:97988308 C>G,T), RS1007389807 (7:97991748 A>T), RS1007609165 (7:97985766 A>C), RS1008054172 (7:97988986 A>G), RS1008075966 (7:97985359 C>T), RS1008279193 (7:97992062 A>C), RS1008562584 (7:97984644 G>C), RS1009031376 (7:97984413 GA>G), RS1010343607 (7:97984453 C>T), RS1010910150 (7:97990625 A>T), RS1011577503 (7:97987979 G>A), RS1011860582 (7:97989639 C>T), RS1014303245 (7:97991356 T>C)

Disease associations

OMIM: gene MIM:620522 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

2 associations (top):

StudyTraitp-value
GCST001099_14Sudden cardiac arrest2.000000e-06
GCST006922_15Regular attendance at a religious group9.000000e-09

EFO canonical traits (2, from GWAS)

EFO IDTrait name
EFO:0004278sudden cardiac arrest
EFO:0009592social interaction measurement

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

6 total (human), top 6 by PubMed support.

ChemicalActions (top 5)PubMed papers
Benzo(a)pyreneincreases methylation1
Cadmiumdecreases expression1
Folic Aciddecreases expression1
Valproic Acidincreases methylation1
Asbestos, Serpentineincreases methylation1
Lactic Aciddecreases expression1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.